Mohammad Tanashat
Overview
Explore the profile of Mohammad Tanashat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tanashat M, Altobaishat O, Sharaf A, El Din Moawad M, Al-Jafari M, Nashwan A
Vaccine X
. 2024 Sep;
20:100527.
PMID: 39221181
Background: Prevention and treatment of the monkeypox virus (Mpox) remain challenging in areas where it is endemic. This systematic review and meta-analysis aimed to collect this information from various studies...
12.
Tanashat M, Bisht O, Abuelazm M, Altobaishat O, Khan U, Abouzid M
Am J Ther
. 2024 Aug;
32(1):e68-e78.
PMID: 39190713
No abstract available.
13.
Tanashat M, Manasrah A, Abouzid M
Eur J Clin Pharmacol
. 2024 Jul;
80(11):1843-1844.
PMID: 39042275
No abstract available.
14.
Amin A, Ghaly R, Abuelazm M, Ibrahim A, Tanashat M, Arnaout M, et al.
Thromb J
. 2024 May;
22(1):45.
PMID: 38807186
Background: Clinical decision support systems (CDSS) have been utilized as a low-cost intervention to improve healthcare process measures. Thus, we aim to estimate CDSS efficacy to optimize adherence to oral...
15.
Altobaishat O, Abouzid M, El Din Moawad M, Sharaf A, Al-Ajlouni Y, Umar T, et al.
Endocrine
. 2024 Apr;
85(2):545-557.
PMID: 38658475
Introduction: Growth hormone deficiency occurs when the pituitary gland does not produce enough growth hormone. Norditropin®, a recombinant human growth hormone, and Sogroya®, an albumin-binding growth hormone derivative, are prescribed...
16.
Al-Ajlouni Y, Al Taani O, Shamaileh G, Nagi Y, Tanashat M, Al-Bitar F, et al.
BMC Public Health
. 2024 Mar;
24(1):879.
PMID: 38515115
Background: Cardiovascular Disease (CVD) is the leading cause of mortality worldwide. While countries in the Arab world continue to lack public health data and be severely understudied in health research,...
17.
Tanashat M, Manasrah A, Abouzid M
Eur J Clin Pharmacol
. 2024 Mar;
80(7):951-963.
PMID: 38498097
Background: Dapagliflozin and empagliflozin are antidiabetic medications. They are the first two sodium-glucose cotransporter-2 inhibitors (SGLT2i) to receive the US Food and Drug Administration approval to manage heart failure. Emerging...
18.
Abuelazm M, Mohamed I, Naeem A, Khlidj Y, Tanashat M, Katamesh B, et al.
Eur J Gastroenterol Hepatol
. 2024 Feb;
36(4):371-381.
PMID: 38407890
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent metabolic disorder characterized by excessive hepatic fat accumulation. Intermittent fasting (IF) has emerged as a potential therapeutic strategy with the ability...
19.
Amin A, Khlidj Y, Abuelazm M, Ibrahim A, Tanashat M, Imran M, et al.
Cardiooncology
. 2024 Feb;
10(1):10.
PMID: 38395955
Background: Cardiotoxicity is one of the most common adverse events of the chemotherapy. Physical exercise was shown to be cardioprotective. We aim to estimate the efficacy and safety of exercise...
20.
Abuelazm M, Rezq H, Mahmoud A, Tanashat M, Salah A, Saleh O, et al.
Eur J Trauma Emerg Surg
. 2024 Feb;
50(6):2697-2707.
PMID: 38367091
Background And Objective: Plasma is a critical element in hemostatic resuscitation post-injury, and its prompt administration within the prehospital setting may reduce the complications resulting from hemorrhage and shock. Our...